Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
Colorectal cancer resection is a surgical procedure to remove the cancerous segment of the colon or rectum along with surrounding lymph nodes, aiming to eliminate the tumor and prevent its spread.
Why it may be consideredIt is typically recommended after diagnosis via colonoscopy and biopsy, often combined with chemotherapy or radiotherapy depending on the cancer stage. The goal is complete tumor clearance while preserving bowel function wherever possible.
Key distinction: Most Popular
Laparoscopic colorectal cancer surgery is a minimally invasive technique used to remove cancerous tumors from the colon or rectum along with surrounding lymph nodes, using small incisions and a camera-guided approach instead of open surgery.
Why it may be consideredIt is performed to achieve complete tumor removal while reducing blood loss, pain, and recovery time compared to conventional open colectomy. This approach is suitable for most early to moderately advanced colorectal cancers depending on tumor location and staging.
Key distinction: Most Popular
Laparoscopic colorectal resection is a minimally invasive surgery to remove a diseased segment of the colon or rectum, most commonly performed for colorectal cancer, but also for severe diverticulitis, inflammatory bowel disease, or polyps that cannot be removed endoscopically.
Why it may be consideredUsing small incisions, a camera and specialized instruments, the surgeon removes the affected bowel segment and reconnects the healthy ends, offering less pain, shorter hospital stay and faster recovery than open surgery. It is often combined with lymph node removal for accurate cancer staging.
Key distinction: Most Popular
Colorectal cancer surgery involves the surgical removal of cancerous tumors from the colon or rectum, along with surrounding lymph nodes, to prevent the spread of disease and achieve cure or long-term control.
Why it may be consideredThe approach and extent of surgery depend on tumor location, stage, and involvement of nearby structures. It is often combined with chemotherapy or radiotherapy for optimal outcomes.
Key distinction: Complex Cases
External Beam Radiotherapy (EBRT) uses precisely targeted high-energy X-ray beams from a machine outside the body to destroy cancer cells or shrink tumors in the rectum or colon area.
Why it may be consideredIt is commonly used before surgery (neoadjuvant) to shrink a rectal tumor, after surgery (adjuvant) to eliminate residual cells, or for palliative symptom control in advanced colorectal cancer. Treatment is typically delivered as a series of short daily sessions over several weeks under the guidance of a radiation oncologist.
Key distinction: Standard Option
Chemotherapy is a systemic cancer treatment that uses potent drugs to destroy or slow the growth of cancer cells, either as a standalone treatment or combined with surgery and radiation therapy.
Why it may be consideredIt is typically administered in cycles over several weeks to months, tailored to the cancer type, stage, and patient's overall health. GAF Healthcare connects international patients with leading Indian oncology centers offering world-class chemotherapy protocols at a fraction of Western costs.
Key distinction: Most Common
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma.
Why it may be consideredIt is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Key distinction: Most Common
Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells.
Why it may be consideredIt is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.
Key distinction: Essential First Step
